Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Repligen terminates rPF4 development agreement

April 26, 1996

Antiandrogen research at Roussel Uclaf

April 26, 1996

Topotecan approval recommended

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Glaxo Wellcome/BioChem Pharma antitumor agent described at 211th ACS

April 19, 1996

Photofrin approved for marketing in France

April 19, 1996

NU-1064 and NU-1076, PARP inhibitors

April 19, 1996

Dipyridamole analogue more potent than parent drug

April 19, 1996

Cancer Research Center, Moscow, presents MDR inhibitors at NCI-EORTC

April 19, 1996

ONYX-015 enters clinical testing

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...